Stay updated on TAPUR Study: Targeted Drug Clinical Trial
Sign up to get notified when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.

Latest updates to the TAPUR Study: Targeted Drug Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record now shows additional recruitment sites (including Puerto Rico locations) and updated point-of-contact details, while certain therapeutic arms (regorafenib and palbociclib) have been removed from the arms section.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, indicating a minor version bump to the page.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded a new publication entry for Veljovich et al. on Palbociclib in ovarian cancer with CDKN2A alterations to the Publications section. The page revision was updated from v3.6.3 to v3.6.4.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, reflecting an updated revision of the page's metadata.SummaryDifference0.0%

- Check97 days agoChange DetectedThe revision tag updated from v3.5.4 to v3.5.5, signaling a minor backend or documentation update to the page without altering displayed study details.SummaryDifference0.0%

- Check104 days agoChange DetectedPuerto Rico site contacts were added (Natalia Ortiz and Maria Cruz Correa). The total number of locations was updated to 181, and the site list expanded accordingly.SummaryDifference0.8%

Stay in the know with updates to TAPUR Study: Targeted Drug Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.